RhumbLine Advisers’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-6,167
Closed -$53K 4216
2025
Q1
$53K Sell
6,167
-707
-10% -$6.08K ﹤0.01% 3558
2024
Q4
$246K Buy
6,874
+200
+3% +$7.15K ﹤0.01% 3097
2024
Q3
$315K Sell
6,674
-369
-5% -$17.4K ﹤0.01% 2996
2024
Q2
$354K Sell
7,043
-115
-2% -$5.78K ﹤0.01% 2905
2024
Q1
$802K Buy
7,158
+755
+12% +$84.6K ﹤0.01% 2377
2023
Q4
$371K Hold
6,403
﹤0.01% 2836
2023
Q3
$203K Sell
6,403
-192
-3% -$6.1K ﹤0.01% 3155
2023
Q2
$542K Buy
6,595
+261
+4% +$21.5K ﹤0.01% 2638
2023
Q1
$651K Buy
6,334
+215
+4% +$22.1K ﹤0.01% 2313
2022
Q4
$896K Buy
6,119
+211
+4% +$30.9K ﹤0.01% 2191
2022
Q3
$998K Buy
5,908
+486
+9% +$82.1K ﹤0.01% 2130
2022
Q2
$626K Buy
5,422
+2,227
+70% +$257K ﹤0.01% 2370
2022
Q1
$319K Sell
3,195
-36
-1% -$3.59K ﹤0.01% 2622
2021
Q4
$502K Sell
3,231
-79
-2% -$12.3K ﹤0.01% 2507
2021
Q3
$780K Buy
3,310
+97
+3% +$22.9K ﹤0.01% 2342
2021
Q2
$1.09M Buy
3,213
+498
+18% +$169K ﹤0.01% 2210
2021
Q1
$1.1M Sell
2,715
-87
-3% -$35.2K ﹤0.01% 2152
2020
Q4
$1.86M Buy
2,802
+215
+8% +$143K ﹤0.01% 1881
2020
Q3
$1.2M Sell
2,587
-179
-6% -$83.3K ﹤0.01% 1917
2020
Q2
$1.62M Buy
2,766
+638
+30% +$373K ﹤0.01% 1847
2020
Q1
$310K Buy
2,128
+274
+15% +$39.9K ﹤0.01% 2389
2019
Q4
$266K Buy
1,854
+98
+6% +$14.1K ﹤0.01% 2648
2019
Q3
$69K Buy
1,756
+177
+11% +$6.96K ﹤0.01% 2914
2019
Q2
$160K Buy
1,579
+909
+136% +$92.1K ﹤0.01% 2844
2019
Q1
$88K Buy
670
+26
+4% +$3.42K ﹤0.01% 2875
2018
Q4
$66K Buy
644
+204
+46% +$20.9K ﹤0.01% 2921
2018
Q3
$110K Sell
440
-31
-7% -$7.75K ﹤0.01% 2852
2018
Q2
$211K Buy
+471
New +$211K ﹤0.01% 2707